Abstract
BackgroundBiologic agents are effective therapies for rheumatoid arthritis (RA). It has been suggested that biologic taper and discontinuation may be a viable option for a subset of RA patients whose...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
